BALYASNY ASSET MANAGEMENT L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Leap Therapeutics, Inc. Common Stock, par value $0.001 per share (LPTX)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Leap Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
LPTX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 06:22:01 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 0% 0 0 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 0% 0 0 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self